251 related articles for article (PubMed ID: 27914099)
1. Discrepancies between multicriteria decision analysis-based ranking and intuitive ranking for pharmaceutical benefit-risk profiles in a hypothetical setting.
Hoshikawa K; Ono S
J Clin Pharm Ther; 2017 Feb; 42(1):80-86. PubMed ID: 27914099
[TBL] [Abstract][Full Text] [Related]
2. Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology.
Badia X; Aguarón A; Fernández A; Gimón A; Nafria B; Gaspar B; Guarga L; Gálvez M; Fuentes M; Paco N; Saldaña R
Int J Technol Assess Health Care; 2019 Jan; 35(1):56-63. PubMed ID: 30730288
[TBL] [Abstract][Full Text] [Related]
3. Prioritizing Healthcare Interventions: A Comparison of Multicriteria Decision Analysis and Cost-Effectiveness Analysis.
Wilson R; Chua J; Pryymachenko Y; Pathak A; Sharma S; Abbott JH
Value Health; 2022 Feb; 25(2):268-275. PubMed ID: 35094800
[TBL] [Abstract][Full Text] [Related]
4. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
5. A simple way to unify multicriteria decision analysis (MCDA) and stochastic multicriteria acceptability analysis (SMAA) using a Dirichlet distribution in benefit-risk assessment.
Saint-Hilary G; Cadour S; Robert V; Gasparini M
Biom J; 2017 May; 59(3):567-578. PubMed ID: 28187230
[TBL] [Abstract][Full Text] [Related]
6. Collaborative environmental planning in river management: an application of multicriteria decision analysis in the White River Watershed in Vermont.
Hermans C; Erickson J; Noordewier T; Sheldon A; Kline M
J Environ Manage; 2007 Sep; 84(4):534-46. PubMed ID: 17029759
[TBL] [Abstract][Full Text] [Related]
7. Guidance toward the implementation of multicriteria decision analysis framework in developing countries.
Inotai A; Nguyen HT; Hidayat B; Nurgozhin T; Kiet PHT; Campbell JD; Németh B; Maniadakis N; Brixner D; Wijaya K; Kaló Z
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):585-592. PubMed ID: 30092151
[TBL] [Abstract][Full Text] [Related]
8. Amplifying Each Patient's Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients.
Marsh K; Caro JJ; Hamed A; Zaiser E
Appl Health Econ Health Policy; 2017 Apr; 15(2):155-162. PubMed ID: 27928659
[TBL] [Abstract][Full Text] [Related]
9. A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment.
Nixon R; Dierig C; Mt-Isa S; Stöckert I; Tong T; Kuhls S; Hodgson G; Pears J; Waddingham E; Hockley K; Thomson A
Biom J; 2016 Jan; 58(1):8-27. PubMed ID: 25619173
[TBL] [Abstract][Full Text] [Related]
10. Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States.
Mendola ND; Oehrlein E; Perfetto EM; Westrich K; McQueen RB
J Manag Care Spec Pharm; 2022 Oct; 28(10):1190-1196. PubMed ID: 36125060
[No Abstract] [Full Text] [Related]
11. Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut).
Guarga L; Badia X; Obach M; Fontanet M; Prat A; Vallano A; Torrent J; Pontes C
Orphanet J Rare Dis; 2019 Jun; 14(1):157. PubMed ID: 31248421
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Multicriteria Decision Analysis Algorithms in Food Safety: A Case Study on Emerging Zoonoses Prioritization.
Garre A; Boué G; Fernández PS; Membré JM; Egea JA
Risk Anal; 2020 Feb; 40(2):336-351. PubMed ID: 31469918
[TBL] [Abstract][Full Text] [Related]
13. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
[TBL] [Abstract][Full Text] [Related]
14. Two approaches to incorporate clinical data uncertainty into multiple criteria decision analysis for benefit-risk assessment of medicinal products.
Wen S; Zhang L; Yang B
Value Health; 2014 Jul; 17(5):619-28. PubMed ID: 25128056
[TBL] [Abstract][Full Text] [Related]
15. Multiple criteria decision analysis for health technology assessment.
Thokala P; Duenas A
Value Health; 2012 Dec; 15(8):1172-81. PubMed ID: 23244821
[TBL] [Abstract][Full Text] [Related]
16. Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study.
Goetghebeur MM; Wagner M; Nikodem M; Zyla A; Micaleff A; Amzal B
Ther Innov Regul Sci; 2016 Sep; 50(5):620-631. PubMed ID: 30231761
[TBL] [Abstract][Full Text] [Related]
17. Multicriteria decision analysis in ranking of analytical procedures for aldrin determination in water.
Tobiszewski M; Orłowski A
J Chromatogr A; 2015 Mar; 1387():116-22. PubMed ID: 25704773
[TBL] [Abstract][Full Text] [Related]
18. Multicriteria decision analysis in oncology.
Adunlin G; Diaby V; Montero AJ; Xiao H
Health Expect; 2015 Dec; 18(6):1812-26. PubMed ID: 24635949
[TBL] [Abstract][Full Text] [Related]
19. How can multi criteria decision analysis support value assessment of pharmaceuticals? - Findings from a systematic literature review.
Kolasa K; Zah V; Kowalczyk M
Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):379-391. PubMed ID: 29707985
[TBL] [Abstract][Full Text] [Related]
20. Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development.
Kremer IEH; Jongen PJ; Evers SMAA; Hoogervorst ELJ; Verhagen WIM; Hiligsmann M
BMC Med Inform Decis Mak; 2021 Apr; 21(1):123. PubMed ID: 33836742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
